Myriad Genetics prelim Q4 revenue $196-197M; GAAP EPS loss ($0.35)-($0.36); adjusted EPS $0.02-0.03

MYRIAD GENETICS INC

2023-FY EPS reported -$3.18 revenue$753,200,000

Preliminary Q4 2023 revenue $196-197M; GAAP diluted EPS loss ($0.35)-($0.36); adjusted EPS $0.02-$0.03.
FY2023 revenue growth reaffirmed at least 10% YoY; prenatal volume growth at least 10% in Q4.
Reaffirmed positive adjusted operating cash flow in Q4 2023; guided estimated cash and credit at year-end.
Excluded items for non-GAAP: stock-based comp ~$10.3M, amortization ~$10.7M, transformation costs ~$14.1M, legal ~$0.6M, tax ~$2.0M.
Reaffirmed FY2023 revenue and non-GAAP guidance originally provided on Nov 6, 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MYRIAD GENETICS INC reported fourth quarter 2023 results: revenue between approximately $196 and $197 million, EPS diluted GAAP earnings per share of between ($0.35) an d ($0.36), adj usted earnings per share of between $0.02 and $0.03. Guidance reaffirmed.

Period: fourth quarter 2023
Revenue: between approximately $196 and $197 million
EPS: diluted GAAP earnings per share of between ($0.35) an d ($0.36), adj usted earnings per share of between $0.02 and $0.03
Guidance: reaffirmed
Result: preliminary results

Exact text from the filing

The Company also disclosed preliminary financial data for the fourth quarter of 2023, specifically that the Company expects fourth quarter 2023 revenue of between approximately $196 and $197 million, diluted GAAP earnings per share of between ($0.35) an d ($0.36), adj usted earnings per share of between $0.02 and $0.03, and GAAP and adjusted gross margin of approximately 70%.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

MYRIAD GENETICS INC filing history →

Source: SEC EDGAR

accession 0000899923-24-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.